Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

BACKGROUND: Erythropoiesis-stimulating agents reduce anaemia in patients with cancer and could improve their quality of life, but these drugs might increase mortality. We therefore did a meta-analysis of randomised controlled trials in which these drugs plus red blood cell transfusions were compare...

Descripció completa

Dades bibliogràfiques
Autors principals:	Bohlius, J, Schmidlin, K, Brillant, C, Schwarzer, G, Trelle, S, Seidenfeld, J, Zwahlen, M, Clarke, M, Weingart, O, Kluge, S, Piper, M, Rades, D, Steensma, D, Djulbegovic, B, Fey, M, Ray-Coquard, I, Machtay, M, Moebus, V, Thomas, G, Untch, M, Schumacher, M, Egger, M, Engert, A
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents
per: Thomy Tonia, et al.
Publicat: (2013-05-01)

Impact of unlinked deaths and coding changes on mortality trends in the Swiss National Cohort
per: Schmidlin Kurt, et al.
Publicat: (2013-01-01)

Adrenergic Modulation of Erythropoiesis After Trauma
per: Jennifer A. Munley, et al.
Publicat: (2022-03-01)

Erythropoiesis: insights into pathophysiology and treatments in 2017
per: Andrea Zivot, et al.
Publicat: (2018-03-01)

Normal erythropoiesis and development of multiple myeloma
per: Bouchnita A., et al.
Publicat: (2015-01-01)

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
per: Steurer, M, et al.
Publicat: (2006)

Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis
per: Steurer, M, et al.
Publicat: (2005)

Cancer, a disease of aging (part 2) – risk factors for older adult cancer mortality in Switzerland 1991–2008
per: Kurt Schmidlin, et al.
Publicat: (2012-08-01)

Cancer, a disease of aging (part 1) – trends in older adult cancer mortality in Switzerland 1991–2008
per: Kurt Schmidlin, et al.
Publicat: (2012-08-01)

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin’s lymphoma: a systematic review
per: Christine Herbst, et al.
Publicat: (2010-03-01)

Modeling erythropoiesis.
per: Saraf, Pritha.
Publicat: (2012)

Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis
per: F. Morceau, et al.
Publicat: (2009-01-01)

Mechanisms of Impaired Erythropoiesis in Sepsis
per: E. N. Barkova, et al.
Publicat: (2008-02-01)

Modeling and optimal regulation of erythropoiesis subject to benzene intoxication
per: H. T. Banks, et al.
Publicat: (2004-02-01)

Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia
per: Taylor, Alison M, et al.
Publicat: (2021)

The role of glucocorticoids in erythropoiesis
per: Lars L. P. Hanssen, et al.
Publicat: (2025-02-01)

Editorial: Stress erythropoiesis
per: Jaira Ferreira de Vasconcellos, et al.
Publicat: (2023-02-01)

Chk1 haploinsufficiency results in anemia and defective erythropoiesis.
per: Nathan C Boles, et al.
Publicat: (2010-01-01)

PB1918: MOLECULAR CHARACTERIZATION AND CLINICAL RELEVANCE OF ERYTHROPOIESIS IN MIELODYSPLASTIC SYNDROMES.
per: A. Villalba, et al.
Publicat: (2022-06-01)

Preoperative Stimulation of Erythropoiesis in Patients with Anemia
per: V. I. Zagrekov, et al.
Publicat: (2010-04-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
per: N. A. Romanenko, et al.
Publicat: (2014-07-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
per: N. A. Romanenko, et al.
Publicat: (2014-07-01)

Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis
per: Saifan C, et al.
Publicat: (2013-06-01)

Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo.
per: Casals-Pascual, C, et al.
Publicat: (2006)

Nitric Oxide-cGMP Signaling Stimulates Erythropoiesis through Multiple Lineage-Specific Transcription Factors: Clinical Implications and a Novel Target for Erythropoiesis.
per: Tohru Ikuta, et al.
Publicat: (2016-01-01)

Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia
per: Osonoi T, et al.
Publicat: (2023-06-01)

The mechanism of alpha-globin activation during erythropoiesis
per: Higgs, D, et al.
Publicat: (2007)

STAT6-mediated suppression of erythropoiesis in an experimental model of malarial anemia
per: Neeta Thawani, et al.
Publicat: (2009-02-01)

TNF–related apoptosis-inducing ligand (TRAIL) and erythropoiesis: a role for PKCe
per: M Vitale, et al.
Publicat: (2009-06-01)

A critical role for mTORC1 in erythropoiesis and anemia
per: Zachary A Knight, et al.
Publicat: (2014-09-01)

FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D
per: E. S. Lapina, et al.
Publicat: (2016-03-01)

Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
per: Cornel S.G. Mirciov, et al.
Publicat: (2018-10-01)

T cell and monocyte requirements for erythropoiesis.
per: Linch, D, et al.
Publicat: (1982)

Erythropoietin: from erythropoiesis to cardioprotection
per: Liermis Michael Dita Salabert, et al.
Publicat: (2010-08-01)

Ineffective Erythropoiesis in β-Thalassemia
per: Jean-Antoine Ribeil, et al.
Publicat: (2013-01-01)

Erythropoiesis and Iron Exchange in Burns
per: E. N. Barkova, et al.
Publicat: (2007-02-01)

Post-transcriptional regulation of erythropoiesis
per: Yanan Li, et al.
Publicat: (2023-07-01)

Erythropoietin: from erythropoiesis to cardioprotection
per: Liermis Michael Dita Salabert, et al.
Publicat: (2010-08-01)

Epigenetic and Transcriptional Control of Erythropoiesis
per: Maeve Wells, et al.
Publicat: (2022-03-01)

Iron and Erythropoiesis – Optimizing the Link
per: Mirela TIGLIS, et al.
Publicat: (2020-06-01)